Qin, Q., Jiang, C., Zhang, S., Cole, S., Courtney, K. D., Wang, J., Arafat, W., Vento, J., Tawagi, K., Reizine, N. M., Bilusic, M., McGuire, M., Rowell, A., Wise, D. R., Reimers, M. A., Heath, E. I., Zhang, T. (2025). A phase II study of niraparib (N), abiraterone acetate (AA) plus prednisone (P) for Hispanic/Latino (HL) and non-Hispanic Black (NHB) patients with metastatic hormone sensitive prostate cancer (mHSPC) and deleterious homologous recombination repair alterations (HRRa; HARMONY).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps5130